Methicillin resistant and susceptible Staphylococcus aureus: Appraising therapeutic approaches in the Northwest of Iran

Iranian Journal of Microbiology

Volumn 5, Issue 1, 2013, Pages 56-62

  Hasani, Alka ^a,b   Sheikhalizadeh, Vajihe ^a,b   Hasani, Akbar ^a,c   Naghili, Behrouz ^a,d   Valizadeh, Vahide ^e   Nikoonijad, Ali Reza ^f  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Departments of Medical Microbiology   (Iran)

^c Biochemistry and Laboratory Sciences   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e PASTEUR INSTITUTE OF IRAN   (Iran)

^f URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Increased antibiotic resistance; MIC; Staphylococcus aureus

Indexed keywords

ANTIINFECTIVE AGENT; FUSIDIC ACID; LINEZOLID; OXACILLIN; PSEUDOMONIC ACID; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SURVEILLANCE; DISK DIFFUSION; ERADICATION THERAPY; HUMAN; IRAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS INFECTION; TEST STRIP; VANCOMYCIN INTERMEDIATE STAPHYLOCOCCUS AUREUS;

EID: 84873448030     PISSN: 20083289     EISSN: 20084447     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Kim HB, Jang HC, Nam HJ, Lee YS, Kim BS, Park WB, et al. In Vitro activities of 28 antimicrobial agents against Staphylococcus aureus isolates from tertiarycare hospitals in Korea: a nationwide survey. Antimicrob Agents Chemother 2004; 48: 1124-1127.
2. Askarian M, Zeinalzadeha A, Japoni A, Alborzi A, Memish ZA. Prevalence of nasal carriage of methicillinresistant Staphylococcus aureus and its antibiotic susceptibility pattern in healthcare workers at Namazi hospital, Shiraz, Iran. Int J Infect Dis 2009; 13: 241-247.
3. Burkhardt O, Pletz MW, Mertgen CP, Welte T. Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections. Antimicrob Agents Chemother 2005; 49: 2260-2266.
4. Li JZ, Willke RJ, Rittenhouse BE, Rybak MJ. Effect of linezolid versus vancomycin on length of hospital stay in patients with complicated skin and soft tissue infections caused by known or suspected methicillin-resistant staphylococci: results from a randomized clinical trial. Surg Infect 2003; 4: 57-70.
5. Miguel SG, María A De la T, Gracia M, Beatriz, María JT, Sara D, Francisco JC et al. Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit. JAMA 2010; 303: 2260-2264.
6. Pfaller MA, Castanheira M, Sader HS, Jones RN. Evaluation of the activity of fusidic acid tested against contemporary Gram-positive clinical isolates from the USA and Canada. Int J Antimicrob Agent 2010; 35: 282-287.
7. Howden BP, Grayson ML. Dumb and Dumber-The potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus. Clin Infect Dis. 2006; 42: 394-400.
8. Perlroth J, Kuo M, Tan J, Bayer AS, Miller LG. Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections: a systematic review of the literature. Arch Intern Med 2008; 168: 805-819.
9. Mathew EF, Ioannis AB, Konstantinos NF, Oral rifampin for eradication of Staphylococcus aureus carriage from healthy and sick populations: A systematic review of the evidence from comparative trials. Clin Infect Dis; 42: 394-400.
10. Kloss WE, Bannerman TL (1995). Staphylococcus and Micrococcus. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC and Yolken RH, editors. Manual of Clinical Microbiology. Washington DC: ASM. p. 282-284.
11. Brakstad OG, Aasbakk KJ, Maeland JA. Detection of Staphylococcus aureus by polymerase chain reaction amplification of the nuc Gene. J Clin Microbiol 1992; 30: 1656-660.
12. Murakami K, Minamide W, Wada K, Nakamura E, Teraoka H, Watanabe S. Identification of methicillinresistant strains of staphylococci by polymerase chain reaction. J Clin Microbiol 1991; 29: 2240-244.
13. Sambrook J, Russel, DW (2001). Molecular cloning: a laboratory manual. 3rd ed, New York: Cold spring Harbor.
14. Clinical and Laboratory Standards Institute CLSI. 2006. Performance standards for antimicrobial disk susceptibility testing. Approved standard M2-A7. Clinical Laboratory Standards Institute, Wayne, PA.
15. Finlay JE, Miller LA, Poupard JA. Interpretive criteria for testing susceptibility of staphylococci to mupirocin. Antimicrob Agent Chemother 1997; 41: 1137-1139.
16. European Committee on Antimicrobial Susceptibility Testing EUCAST. 2010. Breakpoint tables for interpretations of MICs and zone diameters. Version 1.1.
17. Yadegar A, Sattari M, Mozafari NA, Goudarzi GHR. Prevalence of the genes encoding aminoglycosidemodifying enzymes and methicillin resistance among clinical isolates of Staphylococcus aureus in Tehran, Iran. Microb Drug Resist 2009; 15: 109-113.
18. Stenstom R, Grafstein E, Romney M, Fahimi J, Harris D, Hunte G, et al. Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus skin and soft tissue infection in a canadian emergency department. CJEM 2009; 11: 430-438.
19. Shittu A, Nübel U, Udo E, Lin J, Gaogakwe S. Characterization of meticillin-resistant Staphylococcus aureus isolates from hospitals in KwaZulu-Natal province, Republic of South Africa. J Med Microbiol 2009; 58: 1219-1226.
20. Struelens M, Mertens R, Groupement P. National survey of methicillin-resistant Staphylococcus aureus in belgian hospital: detection methods, prevalence, trends and infection control measures. Eur J Clin Microbiol Infect Dis 1994; 13: 56-63.
21. Araj GF, Talhouk RS, Simaan CJ and Massad MJ. Discrepencies between mecA PCR and conventional tests used for detection of methicillin resistant Staphylococcus aureus. Inter J Antimicrob Agents1999; 11; 47-52.
22. Chambers HF. Methicillin resistance in staphylococci. Molecular and biochemical basis and clinical implications. Clin Microbiol Rev 1997;10: 781-91.
23. Emaneini M, Aligholi M, Hashemi FB, Jabalameli F, Shahsavan S, Dabiri H, et al. Isolation of vancomycin resistant Staphylococcus aureus in a teaching hospital in Tehran. J Hosp Infect 2007; 66: 92-93.
24. Soltania R, Khalilia H, Rasoolinejadb M, Abdollahi A, Gholami Kh. Antimicrobial susceptibility pattern of Staphylococcus aureus strains isolated from hospitalized patients in Tehran, Iran. Iranian J Pharma Sci 2010; 6: 125-132.
25. Vahdani P, Saifi M, Aslani MM, Asarian AA, Sharafi. Antibiotic resistant patterns in MRSA isolates from patients admitted in ICU and infectious Ward. Tanaffos 2004; 3: 37-44.
26. Conceição T, Tavares A, Miragaia M, hyde K, Airesde-Sousa M, de Lencastre H. Prevalence and clonality of methicillin-resistant Staphylococcus aureus (MRSA) in the Atlantic Azores islands: predmonanace of SCCmec types IV, V and VI. Eur J Clin Microbiol Infect Dis 2010; 29: 543-550.
27. Neela V, Sasikumar M, Ghaznavi GR, Zamberi S, Mariana S. In vitro activies of 28 antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA) from a clinical setting in Malaysia. Southeast Asian J Trop Med Pub Health 2008; 39: 885-892.
28. Mahmood K, Tahir T, Jameel T, Ziauddin A, Aslam HF. Incidence of methicillin-resistant Staphylococcus aureus (MRSA) causing nosocomial infection in a tertiary care hospital. Annals 2010; 16: 91-96.
29. Nathwani D, Morgan M, Masterton RG, Dryden M, Cookson BD, French G, et al. British Society for Antimicrobial Chemotherapy Working Party on Community-onset MRSA Infections: Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community. J Antimicrob Chemother 2008; 61: 976-994.
30. Saderi H, Owlia P, Habibi M. Mupirocin resistance among Iranian isolates of Staphylococcus aureus. Med Sci Monit 2008; 14: 210-213.
31. Nizamuddin S, Irfan S, Zafar A. Evaluation of prevalence of low and high level mupirocin resistance in methicillin resistant Staphylococcus aureus isolates at a tertiary care hospital. J PMA 2011; 61: 519-521.